Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	-45.84	7.76	14.33
Graham Fair Price	-32.15	0.37	0.54
PEG	inf	0.00	< 0.005
Price/Book	21.65	1.52	1.25
Price/Cash Flow	-59.10	3.10	-7.59
Prices/Earnings	-63.60	-1.36	-0.83
Price/Sales	-0.73	0.38	0.38
Price/FCF	-59.10	3.10	-7.59
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	-21.24	0.12	0.15
Operating Margin	1020.80	-0.02	< 0.005
ROA	36.87	-0.05	-0.09
ROE	-0.38	-0.28	25.64
ROIC	< 0.005	-0.04	1623.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.00	-0.07	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.69	0.00	inf
EPS QOQ	-1.00	0.00	inf
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	0.99	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.41	1.04	153.46
Days Sales Outstanding (DSO)	47.76	41.76	-12.55
Inventory Turnover	219.35	86.54	-60.55
Debt/Capitalization	0.61	0.53	-13.19
Quick Ratio	2.10	1.04	-50.26
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	0.19	0.15	-21.31
Cash	0.10	0.14	39.52
Capex	-0.02	< 0.005	50.26
Free Cash Flow	-0.03	0.07	134.06
Revenue	0.62	0.60	-3.57
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	2.23	1.12	-50.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.97	1.04	-73.92
Naive Interpretation	Member

06 - Financial Health · Bad

Rating